Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
The Institute of Chartered Accountants of Scotland (ICAS) and Heriot-Watt University (HWU) have launched a pioneering master’s programme.